Showing 3471-3480 of 5689 results for "".
- Tenpoint Therapeutics Appoints Stephen S. Lane, MD, as Chief Medical Officerhttps://modernod.com/news/tenpoint-therapeutics-appoints-stephen-s-lane-md-as-chief-medical-officer/2486536/Tenpoint Therapeutics announced the appointment of Stephen S. Lane, MD, as Chief Medical Officer (CMO). In this role, Dr. Lane will join the company’s executive leadership team and oversee clinical development strategy, medical affairs, and pharmacovigilance. <
- National Eye Institute Seeks Public Input for 2026–2031 Strategic Planhttps://modernod.com/news/national-eye-institute-seeks-public-input-for-20262031-strategic-plan/2486520/The National Eye Institute (NEI) has issued a Request for Information (RFI) as it begins developing its strategic plan for 2026 through 2031, inviting fe
- Zeiss Expands Ophthalmic Workflow Portfolio in Canada with Diagnostic, Visualization, and Therapeutic Solutionshttps://modernod.com/news/zeiss-expands-ophthalmic-workflow-portfolio-in-canada-with-diagnostic-visualization-and-therapeutic-solutions/2486373/Key Takeaways Zeiss introduced a broader portfolio of diagnostic devices, therapeutic lasers, and digital workflow tools to enhance eye care deliv
- WCO, Alcon Launch Dry Eye Management Map for Optometrists Worldwidehttps://modernod.com/news/wco-alcon-launch-dry-eye-management-map-for-optometrists-worldwide/2486349/The World Council of Optometry (WCO) and Alcon have launched the Dry Eye Management Map, a new online interactive tool designed to help optometrists evaluate and manage dry eye disease in cl
- Edinburgh Biosciences Showcases Light-Based Cataract Treatment Platform at 100% Optical 2026https://modernod.com/news/edinburgh-biosciences-showcases-light-based-cataract-treatment-platform-at-100-optical-2026/2486017/At the 100% Optical 2026 meeting, Edinburgh Biosciences introduced the SDS-100, the company’s proprietary system designed to deliver its Photon Protein Modulation (PPM) treatment. The exhibition provided the first opportunity f
- International Ophthalmology Study Sheds Light on Myopia Biometry Ahead of Refractive Surgeryhttps://modernod.com/news/international-ophthalmology-study-sheds-light-on-myopia-biometry-ahead-of-refractive-surgery/2485825/Key Takeaways The axial length–to–corneal radius (AL/CR) ratio demonst
- Zeiss Launches Collaborative Care Platform to Enhance Connected Ophthalmic Carehttps://modernod.com/news/zeiss-launches-collaborative-care-platform-to-enhance-connected-ophthalmic-care/2485780/Key Takeaways Zeiss Collaborative Care is designed to enables ECPs to
- FDA Officially Shifts to One-Trial Standard for New Drug Approvalshttps://modernod.com/news/fda-officially-shifts-to-one-trial-standard-for-new-drug-approvals/2485753/The FDA has announced a major change to its regulatory framework, formally establishing that a single well-designed pivotal clinical trial will be the new default basis for most drug and therapeutic approvals—replacing the long-standing expectation that two indepen
- Harrow Launches PharmaPack Direct-to-Prescriber Kits for Ophthalmic Medicationshttps://modernod.com/news/harrow-launches-pharmapack-direct-to-prescriber-kits-for-ophthalmic-medications/2485736/Harrow announced the launch of PharmaPack, a new Direct-to-Prescriber (DTP) cash-pay offering designed to expand access to affordable, FDA-approved branded ophthalmic medications. According to Harrow, by providing transparent,
- LKC Technologies, Provider of Visual Electroretinography, Acquired by AMETEKhttps://modernod.com/news/lkc-technologies-provider-of-visual-electroretinography-acquired-by-ametek/2485723/LKC Technologies announced it has been acquired by Ametek, a provider of industrial technology solutions. Financial terms of the deal were not disclosed. LKC Technologies is the maker of t